Repurposing food molecules as a potential BACE1 inhibitor for Alzheimer’s disease

Alzheimer’s disease (AD) is a severe neurodegenerative disorder of the brain that manifests as dementia, disorientation, difficulty in speech, and progressive cognitive and behavioral impairment. The emerging therapeutic approach to AD management is the inhibition of β-site APP cleaving enzyme-1 (BA...

Descripción completa

Detalles Bibliográficos
Autores principales: Mukerjee, Nobendu, Das, Anubhab, Jawarkar, Rahul D., Maitra, Swastika, Das, Padmashree, Castrosanto, Melvin A., Paul, Soumyadip, Samad, Abdul, Zaki, Magdi E. A., Al-Hussain, Sami A., Masand, Vijay H., Hasan, Mohammad Mehedi, Bukhari, Syed Nasir Abbas, Perveen, Asma, Alghamdi, Badrah S., Alexiou, Athanasios, Kamal, Mohammad Amjad, Dey, Abhijit, Malik, Sumira, Bakal, Ravindra L., Abuzenadah, Adel Mohammad, Ghosh, Arabinda, Md Ashraf, Ghulam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9443073/
https://www.ncbi.nlm.nih.gov/pubmed/36072483
http://dx.doi.org/10.3389/fnagi.2022.878276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9443073/
https://www.ncbi.nlm.nih.gov/pubmed/36072483
http://dx.doi.org/10.3389/fnagi.2022.878276

Ejemplares similares